PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL)
CUSIP: 74019P207
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.000005 per share
- Shares outstanding
- 24,241,780
- Total 13F shares
- 4,649,562
- Share change
- +211,624
- Total reported value
- $25,664,758
- Price per share
- $5.52
- Number of holders
- 54
- Value change
- +$1,234,800
- Number of buys
- 25
- Number of sells
- 17
Quarterly Holders Quick Answers
What is CUSIP 74019P207?
CUSIP 74019P207 identifies DTIL - PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74019P207:
Top shareholders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Readout Capital, LP |
13D/G
|
Matthew Smith |
9.4%
|
1,119,311
|
$4,980,934 | +$829,645 | 30 Jun 2025 | |
| NOVARTIS PHARMA AG |
3/4/5
13D/G
|
10%+ Owner |
3.7%
from 13D/G
|
12,407,440
|
$4,590,753 | — | 15 Jun 2022 | |
| Bleichroeder LP |
13F
|
Company |
4.4%
|
1,075,000
|
$4,515,000 | — | 30 Jun 2025 | |
| Lynx1 Capital Management LP |
13F
|
Company |
4.3%
|
1,036,051
|
$4,351,414 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.7%
|
653,649
|
$2,745,326 | — | 30 Jun 2025 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
— |
3.7%
|
406,250
|
$2,165,312 | $0 | 31 Mar 2025 | |
| Weinstein Benjamin |
13D/G
|
— |
5.2%
|
395,489
|
$2,107,956 | $0 | 18 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
405,354
|
$1,702,487 | — | 30 Jun 2025 | |
| Derek Jantz |
3/4/5
|
Chief Scientific Officer, Director |
—
mixed-class rows
|
4,079,565
mixed-class rows
|
$1,509,439 | — | 07 Jun 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.93%
|
225,937
|
$948,000 | — | 30 Jun 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.83%
|
200,000
|
$840,000 | — | 30 Jun 2025 | |
| Matthew R. Kane |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
2,026,513
mixed-class rows
|
$749,324 | — | 07 Jun 2021 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.42%
|
101,206
|
$425,065 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.33%
|
80,277
|
$337,163 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
77,712
|
$326,420 | — | 30 Jun 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
61,901
|
$259,984 | — | 30 Jun 2025 | |
| Quarry LP |
13F
|
Company |
0.24%
|
59,375
|
$249,375 | — | 30 Jun 2025 | |
| Tejara Capital Ltd |
13F
|
Company |
0.24%
|
58,852
|
$247,178 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.24%
|
57,490
|
$241,458 | — | 30 Jun 2025 | |
| Kevin Buehler |
3/4/5
|
Director |
—
mixed-class rows
|
49,137
mixed-class rows
|
$234,961 | +$21,116 | 25 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.22%
|
53,631
|
$225,250 | — | 30 Jun 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.22%
|
53,395
|
$224,000 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.21%
|
51,606
|
$216,746 | — | 30 Jun 2025 | |
| Shari Lisa Pire |
3/4/5
|
Director |
—
mixed-class rows
|
35,028
mixed-class rows
|
$189,875 | — | 27 May 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.17%
|
41,983
|
$176,000 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
40,327
|
$169,373 | — | 30 Jun 2025 | |
| Samuel C. Wadsworth |
3/4/5
|
Director |
—
mixed-class rows
|
14,028
mixed-class rows
|
$161,277 | — | 04 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.11%
|
26,242
|
$110,216 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.07%
|
16,363
|
$68,725 | — | 30 Jun 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.06%
|
13,441
|
$56,452 | — | 30 Jun 2025 | |
| Alan List |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
5,469
mixed-class rows
|
$56,440 | — | 01 May 2024 | |
| Miller Financial Services LLC |
13F
|
Company |
0.04%
|
10,000
|
$42,000 | — | 30 Jun 2025 | |
| David S. Thomson |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
130,768
mixed-class rows
|
$41,260 | — | 23 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
9,821
|
$41,248 | — | 30 Jun 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.03%
|
7,000
|
$29,400 | — | 30 Jun 2025 | |
| Allworth Financial LP |
13F
|
Company |
0.02%
|
4,769
|
$20,030 | — | 30 Jun 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
0.02%
|
4,675
|
$19,636 | — | 30 Jun 2025 | |
| Cape Investment Advisory, Inc. |
13F
|
Company |
0.01%
|
3,500
|
$14,700 | — | 30 Jun 2025 | |
| Shane Barton |
3/4/5
|
VP & Corporate Controller |
—
mixed-class rows
|
33,562
mixed-class rows
|
$12,418 | — | 07 Jun 2023 | |
| Fayaz Khazi |
3/4/5
|
CEO of Elo Life Systems |
—
mixed-class rows
|
65,239
mixed-class rows
|
$8,880 | — | 07 Jun 2021 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.01%
|
1,969
|
$8,270 | — | 30 Jun 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.01%
|
1,600
|
$6,720 | — | 30 Jun 2025 | |
| CWM, LLC |
13F
|
Company |
0%
|
1,005
|
$4,000 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
923
|
$3,877 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
872
|
$3,662 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
471
|
$1,978 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
384
|
$1,613 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
275
|
$1,155 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
164
|
$689 | — | 30 Jun 2025 | |
| Fortitude Family Office, LLC |
13F
|
Company |
0%
|
97
|
$407 | — | 30 Jun 2025 |
Institutional Holders of PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) as of Q3 2025
As of 30 Sep 2025,
PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,649,562 shares.
The largest 10 holders included
Bleichroeder LP, Lynx1 Capital Management LP, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BOOTHBAY FUND MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., and TWO SIGMA INVESTMENTS, LP.
This page lists
54
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
51
Q3 2025 holders
54
Holder diff
3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.